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Background:
 
 Time-to-reperfusion, electrocardiographic and angiographic
parameters are of prognostic relevance in ST-elevation myocardial infarction
(STEMI) patients. We sought to evaluate predictors of Infarct size (IS) and
presence of microvascular obstruction (MO) using delayed hyper-enhance-
ment magnetic resonance imaging (CMR).
 
Methods and results:
 
 We analyzed 128 consecutive STEMI patients reper-
fused by primary PCI within 12 hours after symptom onset. IS and MO were
assessed by delayed hyper-enhancement MRI as percentage of LV mass, 4±2 days
after acute MI. Reperfusion times, TIMI-flow grades pre and post PCI, 90 min ST-
segment resolution, cardiovascular risk factors, Killip-class, and infarct location
were assessed. In patients with TIMI flow 0-1 before PCI, IS was significantly
higher compared to patients with TIMI-flow 2-3 (22±12% versus 16±15%;
p<0.01). Similarly, the extent of MO occurrence was affected by the pre PCI TIMI
flow. A trend toward higher final IS and MO was noted in post PCI TIMI flow.
Patients with TIMI flow 0 to <3 IS was 28±11% versus 20±12% in TIMI-flow =3
(p=0.067). The ST-segment resolution correlated inversely with final IS and pres-
ence of MO (IS r=-0.34, p<0.01; MO r=-0.31, p<0.01). IS was significantly higher
in anterior AMI versus inferior AMI (24±16% versus 17±12%; p<0.01 as well as
MO (9.8±7.8%vs. MO 4.8±3.7%; p=0.01). In a multivariable model the strongest
predictors of IS and MO were pre-PCI TIMI-flow, infarct location, admission
Killip class, and 90 minute ST-segment resolution (p<0.05 for all).
 
Conclusions:
 
 The pre-PCI TIMI flow, infarct location, Killip class and ST-
segment resolution are the strongest predictors of IS and extent of MO as
assed by delayed Hyper-enhancement MRI. CMR allow for strong evaluation
in STEMI patients, giving important information regarding prognostic.
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sPLA2 and Lp-PLA2 are currently being evaluated as potential markers and
therapeutic targets in coronary artery disease. We hypothesized that their mea-
surement, in parallel with CRP, could correlate to the risk of death or myocardial
infarction (MI) in patients with suspected acute coronary syndromes (ACS), pro-
viding thereby important prognostic information. We therefore analysed a cohort
of 419 unselected consecutive patients (mean 61.1 years old ; 63.9 % male) pre-
senting in the emergency room of a large tertiary hospital, without ST-segment
elevation (NSTE) on the baseline ECG, with chest pain (72 %) or other clinical
features considered indicative of ACS. Clinical history, basal troponin I (cTnI)
and CRP measurements were obtained. Final discharge diagnoses were assigned
to the following categories: NSTE-ACS including NSTE-MI and unstable angina
(UA), other cardiac diseases (OCD) or non cardiac diseases (NCD). Follow-up
was obtained in all patients at 40 days. sPLA2 mass, sPLA2 and Lp-PLA2 activ-
ities were measured on the serum samples collected at presentation. The median
sPLA2 activity was significantly higher in NSTE-ACS patients (1.89), than in
OCP and NCP patients (1.45 and 1.43 respectively; p< 0.001). A significant asso-
ciation between sPLA2 mass and diagnosis (p<0.02) was also found, while the
Lp-PLA2 activity appeared not to be associated with the final diagnosis. Patients
with sPLA2 activity or mass at presentation in the highest quartile had a statisti-
cally higher incidence of cardiac death and MI than those with sPLA2 activity or
mass in the lowest quartile (37.5% versus 13.4 %, p=0.0001 and 33.6% versus
16%; p=0.0047, respectively). On the other hand, no association was observed
with Lp-PLA2 activity. Therefore, a single measurement of sPLA2 activity in
 
unselected patients presenting with suspected ACS and no ST-segment elevation,
provides better independent prognostic information than either CRP, sPLA2 mass
or Lp-PLA2, on the risk of death or MI.
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Background:
 
 Erythrocytes transfusion is an independent risk factor for
recurrent ischemic events and mortality in patients suffering from acute coro-
nary syndrome. There is no evidence regarding the underlying mechanism of
such association.
 
Aim:
 
 We hypothesized that red blood cell transfusion would activate
platelet aggregation and we sought to identify which are the pathway involved
in this activation process.
 
Methods:
 
 Healthy volunteers (n=15) provided blood samples that were
mixed with red blood cell (tRBC) obtained from transfusion packs. We
explored platelet activation using light transmission agregometry with four dif-
ferent agonist (ADP, Arachidonic Acid (AA), Collagen and Epinephrin) in 10
volunteers and with flow cytometry for P-selectin and VASP in 5 volunteers.
Measures were obtained at baseline (whole blood from healthy volunteers),
after in vitro transfusion with a 1:4 ratio of tRBC and after in vitro transfusion
with a 1:4 ratio of tRBC and hematocrit adjustement with platelet poor plasma.
All experiment were performed in duplicates.
 
Results:
 
 Theses are preliminary results from the ongoing TRANSFUSION
study. Numerical values are given in table 1. 1/ RBC transfusion activates
platelet aggregation thought ADP and AA pathway. 2/ This effect was con-
firmed by increase in P-Selectin platelet content with flow cytometry and is
independent of an increase in hematocrit. 3/ P2Y12 activation pathways is
involved with an increase in VASP.
 
Conclusions:
 
 Red Blood Cell transfusion activates platelet thought ADP
and AA pathway in healthy volunteers. This may explain the independent
association between transfusion and recurrent ischemic events including mor-
tality in ACS patients.
 
Results of tRBC induced platelet aggregation
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Background:
 
 In patients admitted with acute coronary syndromes (ACS),
those with anemia are at higher risk. However, current risk score systems do
not take into account the presence of anemia.
 
n=10 n=5
Technique Aggregometry (Residual 
Platelet Aggregation %)
P-Selection % PRI 
(%)
 
Agonist ADP AA Collagen Epinephrin 20
 
μ
 
M 
ADP
50
 
μ
 
m 
ADP
VAS
P
Baseline 58,0 79,5 61,6 65,0 33,6 40,2 68,4
After tRBC 
(no adjustement)
70,3 89,1 72,5 59,6 50,5 56,4 83,9
After tRBC 
(adjusted with PPP)
48,1 54,5 74,8
p value 0,03*0,04* 0,13 0,15 ND ND ND
 
(*<0,05; ND=not done)
